Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action
about
sameAs
Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependenceNeurocircuitry of addictionGlutamatergic substrates of drug addiction and alcoholismMultidisciplinary View of Alcohol Use Disorder: From a Psychiatric Illness to a Major Liver DiseaseRational development of addiction pharmacotherapies: successes, failures, and prospectsAcamprosate: A Review of Its Use in Alcohol DependenceAcamprosate produces its anti-relapse effects via calciumEffects of Acamprosate on Neuronal Receptors and Ion Channels Expressed inXenopusOocytesA Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validityResearch in people with psychosis risk syndrome: a review of the current evidence and future directionsAcamprosate.Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addictionTargeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives.How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.Acamprosate reduces ethanol drinking behaviors and alters the metabolite profile in mice lacking ENT1Change of cystine/glutamate antiporter expression in ethanol-dependent rats.Is there evidence for effectiveness of acamprosate in maintaining abstinence in alcohol dependent patients?Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatmentA double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependenceNeurobiology of addiction: a neurocircuitry analysis.The pharmacotherapy of alcohol dependence: a state of the art review.Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study.Acamprosate-responsive brain sites for suppression of ethanol intake and preferenceCritical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawalAcamprosate in the treatment of alcohol dependence.Glutamatergic transmission in the central nucleus of the amygdala is selectively altered in Marchigian Sardinian alcohol-preferring rats: Alcohol and CRF effectsNeuroprotective agents in schizophrenia and affective disorders.Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1.Role of altered structure and function of NMDA receptors in development of alcohol dependence.Safety and efficacy of acamprosate for the treatment of alcohol dependence.A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.Preclinical and clinical pharmacology of alcohol dependence.Cellular and behavioral interactions of gabapentin with alcohol dependencemTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring ratsTreatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication.Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.Alcohol related changes in regulation of NMDA receptor functions
P2860
Q24595863-20E0F916-5A30-4C8E-B7D4-64CB50E69138Q24647156-304972DA-E6BD-4780-A4E3-EB06A22FDC5EQ24648924-E3E071AC-8541-4D7E-9264-DE83806BA2D8Q26771090-BF5A563F-053B-4E66-A7D0-E105EED97487Q27025533-22278AA3-AEFD-4B75-9BF4-03AF53AEC9CDQ28263633-E852E75F-45BD-457B-83B6-42ED4D2CA401Q28299533-13F442A2-CA54-409A-9DAA-40CABBA6838DQ29030837-6E1A8ED9-27BE-4A97-8DF3-ABF213034145Q30275691-DC81D154-800E-414A-881B-1A68CFB583B7Q30440516-28152BA3-A875-44EA-A574-B7FF3C99FB6CQ30447847-BB19EFA2-61B2-4822-931A-D16CCAF9531FQ30475598-89832188-6F84-4134-AB10-F3757C0CF099Q33531891-A1DE6C41-86F9-4FD0-A1EA-759EFF00844AQ33626978-A2480176-792D-42A6-8497-F13C4DFFB6A5Q33821312-7DBC3B8F-5081-4659-AD0F-0E604086D10EQ34073903-D95442CD-26E8-49DA-A113-DFB744D9C438Q34088940-6D2270B3-5CBB-407A-AB83-EB65C027D028Q34155813-FBD1FA46-0AE5-4F3A-89E5-8EC0880BF865Q34292046-564CE93C-5D9C-46EF-A015-BD3B98BD83B8Q34363586-CD74ACE5-6B66-46E2-A189-614BC58788DAQ34411076-14339F65-A590-4D11-9DA0-1914C4FA27A8Q34479286-2E66BE56-5FE1-46A6-B64C-B3016FACEC84Q34535855-C37EA721-6C33-4334-A55A-A609ED48721FQ34543952-9E767221-D05B-43C2-A6C5-9BD6E07E2A5EQ34773574-61F361EB-F95F-416A-906A-379BDCE8825BQ35395058-F21A9A3A-4CFA-4B77-B619-09BC8ED7C4B0Q35589974-D74430E2-A037-4E7A-9390-6EAA72C0BF5EQ36273459-A9A84423-76A6-48AC-9423-675B7D554F09Q36421960-D41D387B-D303-485C-AFB2-52584167AEE9Q36458436-27329A8D-F9B4-40FD-BCD6-93A5B6585DA3Q36493462-6B571C69-C2C4-44AC-9DD3-027DEA99F718Q36499757-910E7559-1F88-4BAA-B9C5-5E6497F1245CQ36590706-E0F345AD-94F7-4ACF-9359-E4FC001B86E7Q36642532-A953077A-97E5-441D-9ED4-98B126870C9EQ36709633-D8C12EB6-EA84-4FC0-AE3F-C73F23D671FFQ36805266-BC6DA092-E12E-4FA3-92A9-97C550513426Q36823796-C1DC49DF-BD45-4E0F-A810-B3FA661B48AFQ36942553-E608383C-215B-4E7B-8671-D06055E65C26Q36998827-5631A535-4B1F-44AE-90EB-A6D7720FA784Q37104136-11976C00-B0DE-4F66-B871-0E7DB400D745
P2860
Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Neuroprotective and abstinence ...... dating the mechanism of action
@ast
Neuroprotective and abstinence ...... dating the mechanism of action
@en
Neuroprotective and abstinence ...... dating the mechanism of action
@nl
type
label
Neuroprotective and abstinence ...... dating the mechanism of action
@ast
Neuroprotective and abstinence ...... dating the mechanism of action
@en
Neuroprotective and abstinence ...... dating the mechanism of action
@nl
altLabel
Neuroprotective and Abstinence-Promoting Effects of Acamprosate
@ast
Neuroprotective and Abstinence-Promoting Effects of Acamprosate
@en
prefLabel
Neuroprotective and abstinence ...... dating the mechanism of action
@ast
Neuroprotective and abstinence ...... dating the mechanism of action
@en
Neuroprotective and abstinence ...... dating the mechanism of action
@nl
P2093
P1433
P1476
Neuroprotective and Abstinence-Promoting Effects of Acamprosate
@en
Neuroprotective and abstinence ...... dating the mechanism of action
@en
P2093
George Koob
John Littleton
Philippe De Witte
Philippe Parot
P356
10.2165/00023210-200519060-00004
P407
P577
2005-01-01T00:00:00Z
P6179
1041003526